Elizabeth Tran
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
104
Citations
4,263
Est. group size
~2
Recurring co-author estimate
Active years
30
Publishing since 1997
This publication record appears to blend at least two distinct lines of work: molecular biology studies of RNA helicases (particularly Dbp2) and gene expression regulation via antisense RNA and 3' untranslated regions, alongside a separate cluster of clinical/translational cancer research covering prostate, renal, and lung cancers, circulating tumor DNA, and cancer survivorship. Because the listed publications span such varied topics and venues (including unrelated items on fairy tales and physical activity in older adults), this record may represent multiple individuals with the same name rather than a single coherent research program. Prospective students should verify institutional affiliation and specific lab focus directly before drawing conclusions about research direction.
Publication output rose from 2017 to a peak around 2019-2020, dropped sharply in 2021, and has since remained at a steady but modest pace of about 4-5 papers per year.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Investigating Metabolically Altered Pathways in Small Cell Lung Cancer: From RNA Sequencing Analysis to Seahorse-Based Functional Validation
Methods and Protocols · 2026
- Concurrent tissue and circulating tumor DNA analysis in renal cell carcinoma: insights from a multimodal database
The Oncologist · 2026
- Navigating Pathways in Prostate Cancer Survivorship: A Comprehensive Review of Challenges, Interventions, and Long-Term Outcomes
Uro · 2025
- Single-cell neural network classifiers reveal that PM21 NK cell expansion is dependent on B cell signaling
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- 2444P Longitudinal characterization of molecular alterations in ctDNA in metastatic castration-resistant prostate cancer (mCRPC)
Annals of Oncology · 2025
- Novel insights on the positive correlation between sense and antisense pairs on gene expression
Wiley Interdisciplinary Reviews - RNA · 2024
- PP01.57 Understanding the molecular mechanism of Supinoxin on Small cell Lung Cancer Therapy
Journal of Thoracic Oncology · 2024
- 12 Concordance Analysis of Tissue and Circulating Tumor DNA (ctDNA) in Renal Cell Carcinoma (RCC): Insights from a Multimodal Real-World Database
The Oncologist · 2024
- The genomic region of the 3′ untranslated region (3′UTR) of <i>PHO84</i>, rather than the antisense RNA, promotes gene repression
Nucleic Acids Research · 2023
- MP55-11 PSMA-GUIDED PROSTATE BIOPSY
The Journal of Urology · 2023
- “Beauty and the Beast” and the Representation of the Female: How Fairy Tales Reinforce and Influence Our Current Understanding of Gender Roles
Chapman University · 2023
- THE EFFECT OF ACTIGRAPHY MEASURED PHYSICAL ACTIVITY ON EXECUTIVE FUNCTION IN OLDER ADULTS
Innovation in Aging · 2022
- MP55-11 PROSTATE CANCER FOCAL THERAPY – LOCATIONS OF POST-ABLATION DISEASE
The Journal of Urology · 2022
- Cellular Localization of Dbp2 and Identification of its Interaction Partners
The FASEB Journal · 2022
- MP09-20 PROSTATE BIOPSY TARGETED TO PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) FOCI
The Journal of Urology · 2022
- Journal of Biological Chemistry×3
- arXiv (Cornell University)×3
- The Journal of Urology×3
- Molecular Cell×2
- Wiley Interdisciplinary Reviews - RNA×2
- Guramrit Singh
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Lauren A. Woodward
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Sarath Chandra Janga
Biochemistry, Genetics and Molecular Biology · Indiana University
- Zheng Xing
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- René M. Arvola
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile